Tailoring echistatin to possess higher affinity for integrin alpha(IIb)beta(3)

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Echistatin is a disintegrin known for high affinity to integrins.
• The Arg-Gly-Asp (RGD) sequence is crucial for integrin binding.

Purpose of the Study:

• To create a modified echistatin with enhanced integrin-binding affinity.
• To investigate the structural and functional impact of altering the RGD region.

Main Methods:

• Chemical synthesis of a mutant echistatin with a modified RGD sequence (CRGDC).
• Purification using reverse-phase HPLC and analysis via peptide mapping and mass spectrometry.
• Inhibition assays to determine binding affinity to integrin alpha(IIb)beta(3).
• Monte Carlo simulations to predict structural changes.

Main Results:

• The mutant echistatin was successfully synthesized and purified, with introduced Cys residues forming a disulfide bond.
• The mutant exhibited a higher affinity for integrin alpha(IIb)beta(3) (IC(50) = 0.12 nM) compared to native echistatin (IC(50) = 0.23 nM).
• Structural analysis suggested the disulfide bond constrains the RGD region into a type II' beta-turn.

Conclusions:

• Conformational constraint within the RGD region can enhance disintegrin affinity for integrins.
• Tailoring echistatin's structure offers a strategy to develop more potent integrin inhibitors.
• The findings contribute to understanding structure-affinity relationships in disintegrins.